Market Overview

The global mice model market size was valued at USD 1.4 billion in 2022 and is projected to reach USD 2.9 billion by 2033, growing at a CAGR of 13.9 % during the forecast period.

Report Scope

 Mice Model Market: Description

The global mice model market refers to the market for laboratory mice that are used as model organisms in scientific research and drug discovery. Mice models are widely used in various fields, including genetics, immunology, oncology, neurology, and toxicology, among others, to study human diseases and develop potential treatments.

Mice models are preferred in research due to their genetic similarity to humans, short reproductive cycle, small size, and ease of handling and maintenance in laboratory settings. They play a crucial role in understanding the underlying mechanisms of diseases, testing new drugs and therapies, and evaluating their efficacy and safety before human trials.

The mice model market encompasses the production, distribution, and usage of mice models in research institutions, pharmaceutical and biotechnology companies, contract research organizations, and academic laboratories worldwide. These mice models are typically genetically modified or selectively bred to mimic specific human diseases or conditions, such as cancer, diabetes, Alzheimer's disease, and cardiovascular disorders.

The market is driven by the increasing demand for personalized medicine, growing prevalence of chronic diseases, advancements in genetic engineering technologies, and rising investments in biomedical research. Additionally, the need for more accurate and reliable animal models to reduce the attrition rate in drug development further fuels the market growth.

Mice share a significant portion of their genetic makeup with humans, making them excellent models for studying human diseases and conditions. This similarity allows researchers to investigate the molecular and genetic basis of various diseases and develop effective therapies.

 Mice Model Market: Key Trends

·         Rising Demand For Personalized Medicine:

With the increasing focus on personalized medicine, there is a growing demand for mice models that closely mimic human genetics and diseases. Researchers are developing genetically modified mice models that carry specific mutations or genetic variations found in patient populations. These models enable the study of individualized treatment responses and facilitate the development of targeted therapies.

·         Expansion of Humanized Mice Models:

Humanized mice models, where human cells, tissues, or immune systems are engrafted into mice, are gaining popularity. These models allow researchers to study human-specific diseases, immune responses, and evaluate the efficacy of human-specific therapeutics. The development of humanized mice models is driven by the need to bridge the gap between preclinical research and clinical trials.

Mice Model Market: Segmental Analysis

By Technology

·         CRISPR/CAS9

·         Embryonic Stem Cell Injection

·         Nuclear Transfer

·         Other Technologies

By Mode

·         Outsourced

·         In-house

By Application

·         Oncology Studies

·         Cardiovascular Studies

·         Genetic Studies

·         Endocrine Metabolic Studies

·         Neurological Studies

·         Immunology & Inflammation studies

·         Other

Mice Model Market: Geographical Landscape

North America holds a prominent position in the mice model market. The United States, in particular, is a major contributor, driven by its robust biomedical research infrastructure, well-established regulatory framework, and presence of leading pharmaceutical and biotechnology companies.

Canada also has a notable presence in the market, with several research institutions and companies actively utilizing mice models for scientific research. Europe is another key region in the mice model market.

Countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed research infrastructure and a strong focus on biomedical research. These countries host renowned academic institutions, contract research organizations (CROs), and biopharmaceutical companies that extensively use mice models for various research applications.

The Asia Pacific region has been experiencing significant growth in the mice model market. Countries like China, Japan, and South Korea have made substantial investments in biomedical research, resulting in the expansion of research capabilities and increased utilization of mice models.

Additionally, emerging economies such as India and Singapore are actively fostering research collaborations and attracting international research organizations and companies to establish their presence in the region.

Although the mice model market in the Middle East and Africa is relatively smaller compared to other regions, there is a growing interest in biomedical research and the use of mice models. Countries like Israel, Saudi Arabia, and South Africa have research institutions and initiatives dedicated to advancing scientific knowledge and promoting the use of animal models in research.

 Mice Model Market: Impact of COVID

The pandemic caused disruptions in global supply chains, including the production and distribution of mice models. Restrictions on transportation, lockdown measures, and reduced workforce in breeding facilities and research institutions led to delays and shortages in the supply of mice models. This affected research activities that heavily rely on the availability of specific mouse strains. COVID-19 pandemic prompted a shift in research priorities towards studying the virus and developing treatments and vaccines.

Many research institutions and companies redirected their resources and efforts towards COVID-19-related research, temporarily reducing the demand for mice models in other areas of study. However, there has also been an increased demand for mice models specifically for COVID-19 research and vaccine development.

The closure of research institutions, universities, and non-essential laboratories during the pandemic resulted in the temporary suspension or reduction of non-COVID-19 research activities.

This pause in research projects affected the demand for mice models, as studies were delayed or put on hold until the resumption of normal research operations. The urgent need for COVID-19 vaccines led to an unprecedented pace of vaccine development. Mice models, particularly genetically modified mice, played a crucial role in preclinical testing of vaccine candidates.

The mice model market witnessed an increased demand for strains suitable for COVID-19 research, such as transgenic mice expressing human ACE2 receptors.

The COVID-19 pandemic highlighted the importance of in vivo studies to understand disease mechanisms and evaluate potential therapeutics. Mice models, as a key tool for in vivo research, gained even more significance during the pandemic.

This emphasis on in vivo studies may lead to a sustained demand for mice models beyond COVID-19 research, as researchers recognize the value of studying diseases and developing treatments in living organisms.

 Mice Model Market: Key Companies

·         Applied StemCell, Inc.

·         Aragen Life Sciences Ltd.

·         Biocytogen Boston Corporation

·         Charles River Laboratories International, Inc.

·         CompareNetworks, Inc.

·         Creative Biolabs.

·         Crown Bioscience by JSR Life Sciences, LLC

·         Cyagen US Inc. by PolyGene AG

·         Envigo by Inotiv, Inc.

·         GenOway

·         Harbour BioMed

Mice Model Market: Regional Scope

North America

·         U.S

·         Canada

·         Mexico

Europe

·         U.K

·         Germany

·         France

·         Italy

·         Spain

·         Rest of Europe

Asia Pacific

·         Chain

·         India

·         Japan

·         South Korea

·         Australia

·         Rest of Asia pacific

South America

·         Brazil

·         Argentina

·         Rest of south America

Middle East and Africa

·         Saudi Arabia

·         UAE

·         Egypt

·         South Africa

·         Rest of Middle East and Africa